PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 27, 2016Frontiers in Immunology184 citationsOpen Access

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis

View Full Paper
EVElisabetta VolpeMSManolo SambucciLBLuca Battistini

Key Points

Key points are not available for this paper at this time.

Abstract

Fas and Fas Ligand (FasL) are two molecules involved in the regulation of cell death. Their interaction leads to apoptosis of thymocytes that fail to rearrange correctly their T cell receptor (TCR) genes and of those that recognize self-antigens, a process called negative selection; moreover, Fas-FasL interaction leads to activation-induced cell death, a form of apoptosis induced by repeated TCR stimulation, responsible for the peripheral deletion of activated T cells. Both control mechanisms are particularly relevant in the context of autoimmune diseases, such as multiple sclerosis (MS), where T cells exert an immune response against self-antigens. This concept is well demonstrated by the development of autoimmune diseases in mice and humans with defects in Fas or FasL. In recent years, several new aspects of T cell functions in MS have been elucidated, such as the pathogenic role of T helper (Th) 17 cells and the protective role of T regulatory (Treg) cells. Thus, in this review, we summarize the role of the Fas-FasL pathway, with particular focus on its involvement in MS. We then discuss recent advances concerning the role of Fas-FasL in regulating Th17 and Treg cells' functions, in the context of MS.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Volpe et al. (2016) studied this question.

synapsesocial.com/papers/6a12ae5c4891eb3ecca41d87https://doi.org/10.3389/fimmu.2016.00382
Ask AI
Helpful
Bookmark
Share
View Full Paper